Relay Therapeutics (RLAY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Analysts expect LiveOne to report an earnings per share (EPS) of $-0.05. The announcement from LiveOne is eagerly anticipated ...

Occidental Petroleum ( OXY -1.10%), also known as Oxy, is an energy company specializing in oil and natural gas exploration, ...

Analysts are estimating that Ucloudlink Group will report an earnings per share (EPS) of $0.02. The announcement from Ucloudlink Group is eagerly anticipated, with investors seeking news of surpassing ...

Discover the Adani Ent Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

Pfizer will report its fiscal second-quarter earnings on Aug. 5. Although we won't know if it'll continue its beats streak ...

Meme stock trading has returned in force. The fear of missing out continues to dominate investor sentiment. Click to read.

Kohl's KSS stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 68 to 75. Please ...

The zone of 24200-24150 will act as important support, and if the index slips below the 24150 level, then it is likely to ...

Below In a recent AI Investor podcast discussion, financial analysts Austin and Eric Bleeker analyzed the current state of Marvell Technology (Nasdaq: MRVL), a leading AI chip company that has ...

Highway Infrastructure shares will list on NSE and BSE at 10 AM. Highway Infrastructure IPO latest GMP is indicating a strong ...